Global pioneer Prof B S Bhoop wins prestigious IPA Eminent Pharmacist Award 2025: Our Bureau, Chennai Friday, November 28, ...
EMA grants Orphan Drug Designation to Kedrion Biopharma’s plasma-derived treatment for aceruloplasminemia, a rare genetic disorder of iron metabolism: Castelvecchio Pascoli, Ita ...
Lupin Foundation earns CRISIL’s highest VO 1A rating for excellence in social responsibility: Our Bureau, Mumbai Friday, November 28, 2025, 16:10 Hrs [IST] Lupin Human Welfare a ...
Mercer Marsh Benefits says intense pressure continues on health benefit costs in line with global medical trends: Our Bureau, Bengaluru Friday, November 28, 2025, 15:40 Hrs [IST] ...
Medicap Healthcare to raise fresh capital of Rs. 240 crore to expand its role in India’s healthcare packaging market: Our Bureau, Bengaluru Friday, November 28, 2025, 15:20 Hrs ...
Hong Kong Department of Health approves IASO Bio’s’ Fucaso to treat relapsed or refractory multiple myeloma: Shanghai, Nanjing Friday, November 28, 2025, 14:00 Hrs [IST] IASO ...
Cytiva and Veeda Lifesciences drive biopharma innovation with new host cell protein services center: Our Bureau, Bengaluru Friday, November 28, 2025, 15:10 Hrs [IST] Cytiva, a Dan ...
Himalaya Wellness partners with Unicommerce to drive omnichannel expansion: Our Bureau, Bengaluru Friday, November 28, 2025, 15:50 Hrs [IST] Himalaya Wellness, has partnered with ...
UK MHRA & NICE receive £2 million from Wellcome to improve safety and effectiveness of digital mental health technologies: United Kingdom Friday, November 28, 2025, 15:00 Hrs [IS ...
High level Ethiopian delegation visits Telangana to study drug regulatory excellence: Peethaambaran Kunnathoor, Chennai ...
IPA Karnataka State Branch bags ‘Special Achievement Award’ for the year 2025: Our Bureau, Bengaluru Thursday, November 27, ...
Cothera Bioscience’s zotiraciclib for treatment of recurrent high-grade glioma receives US FDA fast track designation: San Mateo, California Friday, November 28, 2025, 12:00 Hrs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results